These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Ocular manifestations in Behçet's disease]. Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716 [TBL] [Abstract][Full Text] [Related]
5. How to deal with Behcet's disease in daily practice. Davatchi F; Shahram F; Chams-Davatchi C; Shams H; Nadji A; Akhlaghi M; Faezi T; Sadeghi Abdollahi B Int J Rheum Dis; 2010 May; 13(2):105-16. PubMed ID: 20536594 [TBL] [Abstract][Full Text] [Related]
6. Behçet disease. Lee LA Semin Cutan Med Surg; 2001 Mar; 20(1):53-7. PubMed ID: 11308137 [TBL] [Abstract][Full Text] [Related]
7. [Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review]. Wang Y; Yang L; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):910-914. PubMed ID: 27752180 [TBL] [Abstract][Full Text] [Related]
8. [Behçet's disease--difficulty in diagnostic and management]. Swierkot J; Borysewicz K; Szechiński J Pol Arch Med Wewn; 2005 Jun; 113(6):580-4. PubMed ID: 16454449 [TBL] [Abstract][Full Text] [Related]
9. [Acute psychosis and Behçet's disease: a case report]. Nkam I; Cottereau MJ Encephale; 2006; 32(3 Pt 1):385-8. PubMed ID: 16840933 [TBL] [Abstract][Full Text] [Related]
10. Adult Behcet's disease in Iran: analysis of 6075 patients. Davatchi F; Chams-Davatchi C; Shams H; Nadji A; Faezi T; Akhlaghi M; Sadeghi Abdollahi B; Ashofteh F; Ghodsi Z; Mohtasham N; Shahram F Int J Rheum Dis; 2016 Jan; 19(1):95-103. PubMed ID: 26258691 [TBL] [Abstract][Full Text] [Related]
11. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis. Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978 [TBL] [Abstract][Full Text] [Related]
12. [Behçet's syndrome : Current diagnostics and treatment]. Kötter I Z Rheumatol; 2020 Nov; 79(9):873-882. PubMed ID: 33052453 [TBL] [Abstract][Full Text] [Related]
14. Current therapy in Behcet's disease. Sakane T; Takeno M Skin Therapy Lett; 2000; 5(6):3-5. PubMed ID: 10889570 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis]. Zlatanović G; Jovanović S; Veselinović D; Zivković M Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of Behcet's Disease in the American Southwest. Muruganandam M; Rolle NA; Sibbitt WL; Cook GB; Emil NS; Fangtham M; Reiter KJ; Bankhurst AD Semin Arthritis Rheum; 2019 Oct; 49(2):296-302. PubMed ID: 30952423 [TBL] [Abstract][Full Text] [Related]
17. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease. Park JY; Chung YR; Lee K; Song JH; Lee ES Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144 [TBL] [Abstract][Full Text] [Related]